FDA Approves Eli Lilly’s GLP-1 Pill

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.

Related posts:

Your Body Ages Faster Because of Extreme Heat Trump’s Tylenol Directive Could Actually Increase Autism Rates, Researchers Warn Data Holds the Key in Slowing Age-Related Illnesses The South Carolina Measles Outbreak Is Slowing Down